Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. - Wikidata - wikimedia - TriplyDB

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

http://www.wikidata.org/entity/Q34519189

about

Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium.Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications.The anti-Candida activity by Ancillary Proteins of an Enterococcus faecium strain.Candida albicans Cek1 mitogen-activated protein kinase signaling enhances fungicidal activity of salivary histatin 5 Diagnostic model of saliva peptide finger print analysis of oral squamous cell carcinoma patients using weak cation exchange magnetic beads.Tissue-specific human beta-defensins (HBD)-1, HBD-2 and HBD-3 secretion profile from human amniochorionic membranes stimulated with Candida albicans in a two-compartment tissue culture system Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.Can lactoferrin prevent neonatal sepsis and necrotizing enterocolitis?Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis.Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils.Lactoferrin and the newborn: current perspectives.Normal human gingival epithelial cells sense C. parapsilosis by toll-like receptors and module its pathogenesis through antimicrobial peptides and proinflammatory cytokines.Structural Characterization of Histatin 5-Spermidine Conjugates: A Combined Experimental and Theoretical Study.Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity.Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms.The corneal expression of antimicrobial peptides during experimental fungal keratitis.

P2860

Q30848083-16C496DC-7984-415E-9836-D608BD967F49 Q33233557-F13337F1-3CFB-4942-942F-46A6165DEAE5 Q34973666-0094C81A-67C8-47F8-8D6E-633BAF9C67A2 Q35584987-45BB59BE-2772-4308-B3F8-CE5292118617 Q35607648-CACFA1E0-4834-485D-AAFF-7464F56BFA8C Q35693688-77F13FC2-690F-4EAA-8BF0-BDCF96C794B4 Q36390494-A7617F02-8EEF-47D8-B8A6-738035C5652D Q36569737-48294766-C35B-419A-AACE-6DF6F6FF3433 Q37116400-C35C63E3-368E-4A9F-A889-720B5596BFD3 Q37503327-1D0ECAA5-8915-4C61-B1D0-11D94AD22D2A Q37544689-5C1A28DD-7264-4813-859F-D8B51FC0F12D Q37594974-53BF7E7E-224D-4C2E-A3DB-1A546C4EB65D Q38123550-D62672CD-06F1-4093-A7EE-1893A0924A3B Q38888195-3A0554AC-EFB3-4841-A9D1-593B15A5B3DA Q41401065-564C62A6-EA7E-49AD-8D7C-29C49708D17D Q42589056-9BFAF796-E0BD-43B6-8B41-5731DD6FF5E0 Q43003137-C8703141-50C7-47D5-A839-29B1D514DE25 Q45226978-0B2E292C-D452-4F4A-8699-EA82C3F6F32F Q54410145-EA3A3F9E-63B8-4B1A-97A4-D44CEE6AA63B

P2860

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

http://www.wikidata.org/entity/Q34519189

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@ast

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@en

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@nl

type

label

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@ast

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@en

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@nl

prefLabel

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@ast

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@en

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@nl

P1433

Q34519189-82659A31-51E4-4737-89A6-333FA19B9EBC

P1476

Q34519189-81E7824B-9E7B-4CA0-85A0-846D330B8EF6

P2093

Q34519189-62FE3319-141C-4143-9214-FDECCF6AAF96

Q34519189-B32D1925-637B-4C03-87CB-FFFD92E9F0EC

Q34519189-BC9B6E34-C234-485A-8977-E210ACCFBE34

Q34519189-D77CDC6F-5875-4E36-BBE4-0E3A56335AD4

Q34519189-DBBDF283-20CE-478C-B2B7-F938C7F607B9

Q34519189-FE1FA55D-37D5-4351-BAA6-6D4CA7E89A48

P2860

Q34519189-09844CDA-0539-4E25-833B-066636A128F1

Q34519189-0C0E425D-4F50-412A-8029-F226F4551097

Q34519189-15DDE3D7-F6E7-4E2F-9058-BC311525E045

Q34519189-1731389B-E6D3-45BE-BCDD-FAE52BA75D9F

Q34519189-1EF96ADF-167D-4521-AB8D-CA1CA0257ADB

Q34519189-29F38E22-66FF-4891-BF85-2FCF465739D6

Q34519189-2D384710-634F-4E80-93B0-8BEC33C17A7C

Q34519189-365C8D06-1D36-4F90-85BC-679405FF92E6

Q34519189-377291C9-FFB8-471B-AD6C-7EDF81D8B306

Q34519189-3B2258B8-5D3C-4A37-82AB-91B4F8C5371F

P304

Q34519189-7482EED7-CFDC-4EA5-8760-C912331B7B2E

P31

Q34519189-52C8DD31-89DB-474B-A48B-18415D6C3147

P356

Q34519189-6F036D32-583F-45AB-BE2E-D7D4913A9F09

P407

Q34519189-1E5D16B6-2233-47C6-8780-B631C1F4697E

P433

Q34519189-30B0D632-15D1-4F06-B7E1-D92A5CEBBFCC

P478

Q34519189-FCCA6743-1448-4096-AC1C-F502A6DFCFD8

P577

Q34519189-CA8E8584-DF3B-4644-86BF-52DBE7108E3E

P5875

Q34519189-3E73F0F2-AC33-4032-B869-B74D87475F4B

P698

Q34519189-5C69BA53-31C9-4500-B9DA-5152EBAF7FB0

P356

13543784.11.2.309

P1433

Expert Opinion on Investigational Drugs

P1476

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections.

@en

P2093

Antonella Lupetti

http://www.w3.org/2001/XMLSchema#string

Jaap T van Dissel

http://www.w3.org/2001/XMLSchema#string

Jan W van 't Wout

http://www.w3.org/2001/XMLSchema#string

Peter H Nibbering

http://www.w3.org/2001/XMLSchema#string

Romano Danesi

http://www.w3.org/2001/XMLSchema#string

Sonia Senesi

http://www.w3.org/2001/XMLSchema#string

P2860

Candidacidal activities of human lactoferrin peptides derived from the N terminus

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

Discovery of new human beta-defensins using a genomics-based approach

Characterization of low-molecular-weight peptides in human parotid saliva

A peptide antibiotic from human skin

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

P304

309-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.11.2.309

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11530395

http://www.w3.org/2001/XMLSchema#string

P698

11829720

http://www.w3.org/2001/XMLSchema#string